2.10
2 yrs 4 m
1%
1,983.91 Crs
7.79
Mid Growth
SIP 100 & Lumpsum 100
sector funds
Nikhil Mathur
04-Oct-23
NA
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Investors understand that their principal will be at very high risk